Semaglutide in overweight non-diabetic peritoneal dialysis patients: a real-world single-center experience

Conflict of interest

Authors declare that no conflict of interest exists.

Ethical approval

Our retrospective study was checked and complied with the standards of the International Conference on Harmonization-Good Clinical Practice and the Declaration of Helsinki, and approved by the Institutional ethical committee of Federico II Hospital (Protocol n. 76/2024).

Informed consent to participate

Informed consent was obtained from all individual participants included in the study.

Comments (0)

No login
gif